CCIA
PGNX

Campbell & Co Investment Adviser’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio PGNX Stock Details PGNX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-21,410
Closed -$172K – 578
2018
Q2 		$172K Buy
21,410
+5,708
+36% +$45.9K 0.13% 324
2018
Q1 		$117K Buy
+15,702
New +$117K 0.1% 331